Focus on Immunizations

Back to articles

Pneumococcal coverage rates low in Medicare beneficiaries

KEY POINT

An assessment of Medicare claims in adults (i.e., ≥65 y) for the 13-valent pneumococcal conjugate vaccine (PCV13) and the 23-valent pneumococcal polysaccharide vaccine (PPSV23) over a 7-year period from 2009 to 2016 showed that vaccination rates were low, despite the long-standing recommendation for the PPSV23 in this patient population and the newer 2014 recommendation to give both vaccines in series.